Your browser doesn't support javascript.
loading
NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism.
Bekiaris, Vasileios; Gaspal, Fabrina; McConnell, Fiona M; Kim, Mi-Yeon; Withers, David R; Sweet, Clive; Anderson, Graham; Lane, Peter J L.
Afiliação
  • Bekiaris V; Medical Research Council Centre for Immune Regulation, School of Medicine, University of Birmingham, Birmingham, UK. vbekiaris@liai.org
Eur J Immunol ; 39(10): 2800-8, 2009 Oct.
Article em En | MEDLINE | ID: mdl-19731363
ABSTRACT
The pathogenic outcomes of viral infection are often reminiscent of a dysfunctional immune system. Thus, cytomegalovirus (CMV) causes disruption of the lymphoid architecture and the functionality of lymphocytes, both of which are features of CD30 deficiency. It was therefore plausible that CD30 might interfere with CMV infection. The present study identifies CD30 as an inducible NK-cell receptor critical for innate immunity against CMV. Expression of CD30 integrates survival signals to NK cells that allow them to prevent viral spread and subsequent disintegration of secondary lymphoid tissue. Deficiency in CD30 results in exaggerated NK cell death and complete abrogation of the lymphoid architecture. Our data define the necessity of NK cells for protection of secondary lymphoid organs and describe a mechanism by which this protection is conferred.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Muromegalovirus / Antígeno Ki-1 / Infecções por Herpesviridae / Imunidade Inata / Tecido Linfoide Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Immunol Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Muromegalovirus / Antígeno Ki-1 / Infecções por Herpesviridae / Imunidade Inata / Tecido Linfoide Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Immunol Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Reino Unido